London funding and investment opportunities

Health, Care and Life Sciences

Access to funding is a critical factor for innovations aiming to tackle London’s most pressing health challenges. As part of the implementation of the London Life Sciences Strategy, we curate a list of current and upcoming health and care funding opportunities aimed at supporting innovative projects.

Have you got an upcoming funding opportunity you’d like us to highlight? Get in touch with us.

Maintained by the Health Innovation Network South London on behalf of our partners

Filter

Refine results:

Status
Status
Funder Type
Funder Type
Funding Type
Funding Type
Eligible Organisation
Eligible Organisation
Geographic eligibility
Geographic eligibility
Area of health, care or life sciences
Area of health, care or life sciences
Maximum Award £m
Maximum Award £m
£5m
Use of funding
Use of funding
Open date
Open date
Closing date
Closing date

Latest

11 opportunities

Open

Innovate UK

Frontier AI: SME Champions, Phase 1

Innovate UK is offering up to £3.1 million in grant funding to support UK SMEs developing novel frontier artificial intelligence (AI) and machine learning technologies. Phase 1 will fund feasibility studies to validate technical innovations with the potential for significant performance improvements and commercial scale-up. Priority themes include AI-enabled health and life sciences, advanced materials, national security and AI safety.

Funder type
Government
Eligibility
Companies
Open

N-CODE

Innovation Challenge: neurological healthcare

The N-CODE Innovation Challenge seeks early-stage ideas that could transform neurological care in the NHS. Proposals may focus on bringing care closer to home, moving from analogue to digital services…

Funder type
Government
Eligibility
Companies, Higher Education Institution (HEI)
Open

SBRI Healthcare

NHS Cancer Programme – Innovation Open Call 4

What challenges does the Innovation Open Call aim to address? Innovation Open Call 4 is looking for innovations that address two challenges: 1. Improving productivity through managing demand or improving capacity on cancer care pathways - to support the NHS in meeting all Cancer Waiting Time standards by March 2029; and/or 2. Driving the earlier detection and diagnosis of cancer (through novel screening, prompt presentation, case-finding, or diagnostic tools) - to help ensure three quarters of people diagnosed with cancer will be cancer-free, or living well with cancer after 5 years, by 2035.

Funder type
Government
Eligibility
Companies, NHS
Open

Innovate UK

UK-Germany Bilateral Collaborative R&D: Round 5

Innovate UK is offering up to £2.4 million to support collaborative research and development projects between UK and German businesses. The competition focuses on industrial research in life sciences, engineering biology and clean energy. UK SMEs must collaborate with at least one independent German SME applying through Germany's ZIM programme. UK partners can request grants of £100,000 to £350,000 per project.

Funder type
Government
Eligibility
Companies, Higher Education Institution (HEI), Other
Open

Innovate UK

Engineering Biology Investor Partnerships Round 1

UK registered SMEs can apply for a share of up to £8 million to develop engineering biology products and services with selected investor partners.

Funder type
Government
Eligibility
Companies
Open

NIHR

i4i Product Development Awards: James Lind Alliance commissioned call

This is the James Lind Alliance (JLA) commissioned route within NIHR's Invention for Innovation (i4i) Product Development Awards, reference 2026/511. It supports the development and evaluation of health and care…

Funder type
Government
Eligibility
Companies, Higher Education Institution (HEI), NHS
Open

NIHR

i4i Product Development Awards: NICE rolling commissioned call

The NIHR i4i Product Development Awards NICE rolling commissioned route (2026/512) supports product-development proposals responding to research recommendations in NICE guidance published or updated during the past five years. It…

Funder type
Government
Eligibility
Companies, Higher Education Institution (HEI), NHS
Open

NIHR; National Health Innovation Centre Singapore

i4i–LeapX joint funding: UK–Singapore (October 2026)

This joint NIHR and National Health Innovation Centre Singapore (NHIC) opportunity helps late-stage healthcare innovations generate the clinical, regulatory and market-entry evidence required for adoption in the UK and Singapore.…

Funder type
Government
Eligibility
Companies, Higher Education Institution (HEI), NHS
Open

Innovate UK

Knowledge Transfer Partnership 2026–27, Round 4

Innovate UK's Knowledge Transfer Partnerships (KTP) support innovation projects in which a business works with a UK research organisation to access expertise it does not hold internally. Suitable projects can…

Funder type
Government
Eligibility
Companies, Higher Education Institution (HEI), Other
Apply Anytime

LifeArc Ventures

Seed to Series B Life Sciences Venture Capital Investment

LifeArc Ventures provides venture capital investment and scientific support to early-stage life sciences companies, typically from Seed to Series B. It invests across therapeutics, HealthTech and MedTech, supporting innovative technologies with the potential to deliver significant patient benefit. Opportunities are considered through direct engagement with the investment team.

Funder type
Charity
Eligibility
Companies
Apply Anytime

Wellcome

Wellcome Discovery Awards

This scheme provides funding for established researchers and teams from any discipline who want to pursue bold and creative research ideas to deliver significant shifts in understanding related to human life, health and wellbeing.

Funder type
Charity
Eligibility
Higher Education Institution (HEI), Other